IL-17 ANTIBODY FORMULATION

The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.

Saved in:
Bibliographic Details
Main Authors WILLIAMS, BARBARA ANN, CORVARI, VINCENT JOHN, MARKHAM, AARON PAUL, DONOVAN, PATRICK DANIEL
Format Patent
LanguageEnglish
Published 25.05.2016
Online AccessGet full text

Cover

More Information
Summary:The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
Bibliography:Application Number: ZA20140005654